EV12: Bard BD EleVation Breast Biopsy Probe 12G x 10cm

Sign in to add this product to your favorites!
| Price: | $49.00 $24.50 EACH |
|---|---|
| Quantity: | |
| In Stock: | 61 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 11 hours 18 minutes and choose overnight shipping at checkout. |
Related Items
EV10 - Size: 10G $249.00 $124.50 per box of 5 Bard BD EleVation Breast Biopsy Probe 10G x 10cm Expired Units in stock: 3 box of 5 | Order Qty |
EV14 - Size: 14G $49.00 $24.50 EACH Bard BD EleVation Breast Biopsy Probe 14G x 10cm Expired Units in stock: 46 | Order Qty |
EV10 - Size: 10G $49.00 $24.50 EACH Bard BD EleVation Breast Biopsy Probe 10G x 10cm Expired Units in stock: 25 | Order Qty |
ENCLRINSERT12G - Size: 12G $27.00 per box of 10 Bard EnCor Insert for Lorad Needle Guide 12G Expired Units in stock: 4 box of 10 | Order Qty |
ECSTUS0112G - Size: 12G $42.00 per box of 5 Bard EnCor Ultrasound Stylet and Coaxial Cannula 12G Expired Units in stock: 29 box of 5 | Order Qty |
AccessGUDID Info
- FDA Product Code: KNW
- FDA Product Code Name: INSTRUMENT, BIOPSY
- GMDN Term Code: 64328
- GMDN Term Name: Side-notch biopsy gun needle
- GMDN Term Description: An invasive tubular surgical instrument designed to be connected to a biopsy gun handpiece (not included) for the automatic extraction of a small tissue sample from an anatomical structure (a biopsy), while causing minimal surrounding tissue damage, for tissue pathological examination/testing. It is a percutaneously-inserted needle with a side-notch cutter at the distal end which when activated causes a sharp, sliding cannula to slice a segment of tissue. It is typically used to obtain samples of soft tissue from the kidneys, prostate, pancreas, liver, and breast, often performed under image guidance. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE